HomeSHRX • CVE
add
Sharp Therapeutics Corp
Nakaraang pagsara
$2.40
Sakop ng taon
$0.23 - $5.00
Market cap
72.03M CAD
Average na Volume
163.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.04M | 56.04% |
Net na kita | -1.09M | -59.71% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -1.03M | -56.45% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.99M | — |
Kabuuang asset | 3.03M | — |
Kabuuang sagutin | 1.61M | — |
Kabuuang equity | 1.42M | — |
Natitirang share | 30.08M | — |
Presyo para makapag-book | 48.00 | — |
Return on assets | -71.51% | — |
Return on capital | -80.22% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.09M | -59.71% |
Cash mula sa mga operasyon | -1.12M | -28.52% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -43.39K | — |
Net change in cash | -1.16M | -4,002.49% |
Malayang cash flow | -748.74K | — |
Tungkol
Itinatag
2021
Headquarters
Website
